Drug Type Synthetic peptide |
Synonyms |
Target |
Action inhibitors |
Mechanism 1,3-beta-glucan synthase inhibitors |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingDiscovery |
First Approval Date- |
Regulation- |
Molecular FormulaC50H80N8O19S |
InChIKeyFXXXVZDWMMLIOC-WDCPJAPNSA-N |
CAS Registry750555-37-4 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Mycoses | Discovery | Japan | 01 Mar 2006 |